![]() |
|||||||||||||||||
| pRetro-U6G shRNA Expression Vector Web Order Page |
|||||||||||||||||
![]() |
|||||||||||||||||
| CG-00003 Design & Construction in pRetro-U6G vector |
|||||||||||||||||
| $400/construct |
|||||||||||||||||
| Give us your target gene name and NCBI accession number, and we will design and make the shRNA expression vector for you . |
|||||||||||||||||
| Click here to go to the Ordering page to check out your orders |
|||||||||||||||||
| * Orders of greater than 3 constructs per gene qualifies for "Service Guarantee" |
|||||||||||||||||
| All users of the custom design and construction service must agree to the terms and conditions listed on the ordering page. Submitting an order form is construed as you have carefully read and agree with such terms and conditions. |
|||||||||||||||||
| The pRetro-U6G vector is a retroviral expression vector modified from murine embryonic stem cell virus (pMSCV) plasmid to express double stranded small hairpin RNA from human U6 snRNA promoter. A compounded puromycin resistance-internal ribosome entry site-green fluorescence protein (puro-IRES-GFP) cassette is inserted behind the phosphoglycerate kinase (PKG) promoter for antibiotic selection and green fluorescence labeling in mammalian cells. Annealed DNA oligos for expression of small hairpin RNAs are to be cloned behind the human U6 snRNA promoter between BamHI and Xho I sites. The small hairpin RNA encoded by pRetro-U6G can be delivered either by standard plasmid transfection approach or by infecting target cells with packaged virus particles. The replication incompetent retroviral particles generated upon transfection of packaging cells, such as Phoenix A or E cells, can infect a wide range of target cells, including hematopoietic and embryonic stem cells, as well as most other mitotically active cells, and achieves high level expression of small hairpin RNAs. All pRetro-U6G derived plasmids should be propagated in suitable host strains such as DH5a, or HB101, under selection of resistance to ampicillin (50 mg/ml). E.coli replication origin: pUC; copy number: high. |
|||||||||||||||||
| Service Description Purchase of the shRNA vector Design & Construction service amounts to entering a service agreement under which Cellogenetics is contractually obligated to: 1. design a requested number of shRNA target sequences based on a set of widely accepted design rules and proprietary design rules. We generally have 50% success rate in obtaining shRNA sequences that have 70% percent “knock-down” efficiency. However, because the functionality of the shRNA target sequences can only be determined empirically, we offer a "Service Guarantee*" to any purchase of three or more constructs to be made for each target gene. 2. synthesize the corresponding DNA oligoes for and generate the ordered shRNA expression constructs. 3. confirm the cloned shRNA coding sequence by DNA sequencing. 4. make glycerol stocks of bacterial clones containing the ordered shRNA expression constructs and prepare technical spec sheet. 5. ship the ordered shRNA expression constructs as glycerol stocks along with all pertinent technical information within 15 business days from the date when the order was placed. * "Service Guarantee" Cellogenetics' Service Guarantee applies to any purchase of three shRNA constructs for each target gene to be designed and constructed by Cellogenetics. During one year from the date when the constructs were sent, Cellogenetics guarantees that at least one of the three shRNA constructs will generate 70% percent “knock-down” or higher efficiency over the target protein or mRNA as either tested individually or collectively in a pool in transfection experiments. The "knock- down" efficiency is defined as percentage reduction in expression level of target protein or mRNA produced from a co-transfected cDNA plasmid in the above experiment using either protein assay, or functional reporter assay, or RNA assay. In the event that none of the three constructs surpasses the 70% "knock-down" efficiency, Cellogenetics agrees to re-design and generates additional shRNA expression constructs for the same target gene free of charge. For this guarantee, Cellogenetics reserves the right to be shown reasonable "proof of failure", which can be the results from any of the above assays or the combination thereof. |
|||||||||||||||||
![]() |
|||||||||||||||||
